KMT2D and neoplasm: Novel targets such as nuclear receptor-binding SET domain protein 3 (NSD3), lysine methyltransferase 2 D (KMT2D), and ubiquitin-specific peptidase 28 (USP28), are related to tumor microenvironment (TME) and immune cells.